{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T04:04:20Z","timestamp":1785470660266,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital.","award":["This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital."],"award-info":[{"award-number":["This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital."]}]},{"name":"This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital.","award":["This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital."],"award-info":[{"award-number":["This work was supported by the Italian Ministry of Health \u201cFondi Ricerca Corrente\u201d to IRCCS Sacro Cuore Don Calabria Hospital."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s15010-024-02390-y","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:02:03Z","timestamp":1726822923000},"page":"383-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescription habits and drugs accessibility for the treatment of non-tuberculous mycobacteria infections in Italy: a multicentric survey from the IRENE study group"],"prefix":"10.1007","volume":"53","author":[{"given":"Giacomo","family":"Stroffolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gaviraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Venuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacoma","family":"Cinnirella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Spotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Codecasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calcagno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the IRENE Study group collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Confalonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Contoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Cristadoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Delfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Gozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gussio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica","family":"Intini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Matteelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Mencarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Anselmo Mori","family":"Pier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pirina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tagliabue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"2390_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1055\/s-0041-1730997","volume":"42","author":"S Tan","year":"2021","unstructured":"Tan S, Kasperbauer S. Nontuberculous Mycobacteria. Semi Respiratory Crit Care Med. 2021;42:567\u201386. https:\/\/doi.org\/10.1055\/s-0041-1730997.","journal-title":"Semi Respiratory Crit Care Med"},{"key":"2390_CR2","doi-asserted-by":"publisher","unstructured":"Lopez-Luis BA, Sifuentes-Osornio J, P\u00e9rez-Guti\u00e9rrez MT, Ch\u00e1vez-Mazari B, Bobadilla-Del-Valle M, Ponce-de-Le\u00f3n A. Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001\u20132017. Braz J Infect Dis. 2020;24(3):213\u2013220. https:\/\/doi.org\/10.1016\/j.bjid.2020.04.012. Epub 2020 May 16. PMID: 32428442.","DOI":"10.1016\/j.bjid.2020.04.012"},{"key":"2390_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10096-020-03826-7","volume":"39","author":"P L\u00f3pez-Roa","year":"2020","unstructured":"L\u00f3pez-Roa P, Aznar E, Cacho J, Cogollos-Agru\u00f1a R, Domingo D, Garc\u00eda-Arata MI, Mill\u00e1n R, P\u00e1ez M, Perez-Cecilia E, Ruiz-Serrano MJ, Sim\u00f3n M, Tato M, Toro C, Valverde JF, Esteban J. Epidemiology of non-tuberculous mycobacteria isolated from clinical specimens in Madrid, Spain, from 2013 to 2017. Eur J Clin Microbiol Infect Dis. 2020;39:1089\u201394. https:\/\/doi.org\/10.1007\/s10096-020-03826-7. (Epub 2020 Jan 24 PMID: 31980987).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2390_CR4","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41598-020-58105-4.PMID:31974461;PMCID:PMC6978455","volume":"10","author":"S Ji","year":"2020","unstructured":"Ji S, Xu W, Sun J, Shi Y, Pan X. Retrospective analysis of patients with non-tuberculous mycobacteria from a primary hospital in Southeast China. Sci Rep. 2020;10:1060. https:\/\/doi.org\/10.1038\/s41598-020-58105-4.PMID:31974461;PMCID:PMC6978455.","journal-title":"Sci Rep"},{"key":"2390_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/22221751.2019.1637702.PMID:31287781;PMCID:PMC6691804","volume":"8","author":"Y Matsumoto","year":"2019","unstructured":"Matsumoto Y, Kinjo T, Motooka D, Nabeya D, Jung N, Uechi K, Horii T, Iida T, Fujita J, Nakamura S. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles. Emerg Microbes Infect. 2019;8:1043\u201353. https:\/\/doi.org\/10.1080\/22221751.2019.1637702.PMID:31287781;PMCID:PMC6691804.","journal-title":"Emerg Microbes Infect."},{"key":"2390_CR6","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020.PMID:32636299;PMCID:PMC8375621","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ Jr, Andrejak C, B\u00f6ttger EC, Brozek J, Griffith DE, Guglielmetti L, Huitt GA, Knight SL, Leitman P, Marras TK, Olivier KN, Santin M, Stout JE, Tortoli E, van Ingen J, Wagner D, Winthrop KL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535. https:\/\/doi.org\/10.1183\/13993003.00535-2020.PMID:32636299;PMCID:PMC8375621.","journal-title":"Eur Respir J"},{"key":"2390_CR7","doi-asserted-by":"publisher","unstructured":"Lange C, B\u00f6ttger EC, Cambau E, Griffith DE, Guglielmetti L, van Ingen J, Knight SL, Marras TK., Olivier KN, Santin M, Stout JE, Tortoli E, Wagner D, Winthrop K, Daley CL, expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary diseases (2022). Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases. The Lancet. Infectious diseases, 22(7), e178\u2013e190. https:\/\/doi.org\/10.1016\/S1473-3099(21)00586-7","DOI":"10.1016\/S1473-3099(21)00586-7"},{"key":"2390_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102058","volume":"70","author":"HOI Pfaeffle","year":"2021","unstructured":"Pfaeffle HOI, Alameer RM, Marshall MH, Houpt ER, Albon DP, Heysell SK. Clofazimine for treatment of multidrug-resistant non-tuberculous mycobacteria. Pulm Pharmacol Ther. 2021;70: 102058. https:\/\/doi.org\/10.1016\/j.pupt.2021.102058.","journal-title":"Pulm Pharmacol Ther"},{"key":"2390_CR9","doi-asserted-by":"publisher","unstructured":"McGuffin SA, Pottinger PS, Harnisch JP (2017) Clofazimine in nontuberculous mycobacterial infections: a growing niche. Open forum infectious diseases, 4(3): ofx147. https:\/\/doi.org\/10.1093\/ofid\/ofx147","DOI":"10.1093\/ofid\/ofx147"},{"key":"2390_CR10","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.3390\/jcm10194581","volume":"10","author":"DH Kim","year":"2021","unstructured":"Kim DH, Kim BG, Kim SY, Huh HJ, Lee NY, Koh WJ, Kim H, Kwon OJ, Jhun BW. In vitro activity and clinical outcomes of clofazimine for nontuberculous mycobacteria pulmonary disease. J Clin Med. 2021;10:4581. https:\/\/doi.org\/10.3390\/jcm10194581.","journal-title":"J Clin Med"},{"key":"2390_CR11","doi-asserted-by":"crossref","unstructured":"Yang B, Jhun BW, Moon SM et al. A clofazimine-containing regimen for the treatment of Mycobacterium abscessus lung disease. Antimicrob Agents Chemother 2017; 61:pii: e02052\u201316.","DOI":"10.1128\/AAC.02052-16"},{"key":"2390_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.638306","volume":"8","author":"MJ Nasiri","year":"2021","unstructured":"Nasiri MJ, Calcagno T, Hosseini SS, Hematian A, Nojookambari NY, Karimi-Yazdi M, Mirsaeidi M. Role of clofazimine in treatment of Mycobacterium avium Complex. Front Med. 2021;8: 638306. https:\/\/doi.org\/10.3389\/fmed.2021.638306.","journal-title":"Front Med"},{"key":"2390_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2217\/fmb-2019-0231","volume":"15","author":"N Riccardi","year":"2020","unstructured":"Riccardi N, Giacomelli A, Canetti D, Comelli A, Intini E, Gaiera G, Diaw MM, Udwadia Z, Besozzi G, Codecasa L, Biagio AD. Clofazimine: an old drug for never-ending diseases. Future Microbiol. 2020;15:557\u201366. https:\/\/doi.org\/10.2217\/fmb-2019-0231.","journal-title":"Future Microbiol"},{"key":"2390_CR14","doi-asserted-by":"publisher","unstructured":"Aliberti S, Codecasa LR, Gori A, Sotgiu G, Spotti M, Di Biagio A, Calcagno A, Nardini S, Assael BM, Tortoli E, Besozzi G, Ferrarese M, Matteelli A, Girardi E, De Lorenzo S, Seia M, Gramegna A, Del Prato B, Terranova L, Oriano M, Sverzellati N, Mirsaeidi M, Chalmers JD, Haworth CS, Loebinger MR, Aksamit T, Winthrop K, Ringshausen FC, Previdi G, Blasi F; IRENE Network. The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: the study protocol. Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):33. https:\/\/doi.org\/10.1186\/s40248-018-0141-8","DOI":"10.1186\/s40248-018-0141-8"},{"key":"2390_CR15","doi-asserted-by":"crossref","unstructured":"Diel R, Jacob J, Lampenius N, et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany. Eur Respir J. 2017;49(4).","DOI":"10.1183\/13993003.02109-2016"},{"key":"2390_CR16","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1513\/AnnalsATS.201503-173OC","volume":"12","author":"SE Strollo","year":"2015","unstructured":"Strollo SE, Adjemian J, Adjemian MK, Prevots DR. The burden of pulmonary nontuberculous mycobacterial disease in the United States. Ann Am Thorac Soc. 2015;12:1458\u201364.","journal-title":"Ann Am Thorac Soc"},{"key":"2390_CR17","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.rmed.2009.04.026","volume":"103","author":"GJ Ballarino","year":"2009","unstructured":"Ballarino GJ, Olivier KN, Claypool RJ, Holland SM, Prevots DR. Pulmonary nontuberculous mycobacterial infections: antibiotic treatment and associated costs. Respir Med. 2009;103:1448\u201355.","journal-title":"Respir Med"},{"key":"2390_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1513\/AnnalsATS.201304-085OC","volume":"11","author":"J Adjemian","year":"2014","unstructured":"Adjemian J, Prevots DR, Gallagher J, Heap K, Gupta R, Griffith D. Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease. Ann Am Thorac Soc. 2014;11:9\u201316. https:\/\/doi.org\/10.1513\/AnnalsATS.201304-085OC.","journal-title":"Ann Am Thorac Soc"},{"key":"2390_CR19","doi-asserted-by":"publisher","first-page":"00109","DOI":"10.1183\/23120541.00109-2018","volume":"4","author":"EE Ricotta","year":"2018","unstructured":"Ricotta EE, Olivier KN, Lai YL, Prevots DR, Adjemian J. Hospital-based antibiotic use in patients with Mycobacterium avium complex. ERJ Open Res. 2018;4:00109\u20132018. https:\/\/doi.org\/10.1183\/23120541.00109-2018.","journal-title":"ERJ Open Res."},{"key":"2390_CR20","doi-asserted-by":"publisher","first-page":"00060","DOI":"10.1183\/23120541.00060-2022","volume":"8","author":"K Suska","year":"2022","unstructured":"Suska K, Amati F, Sotgiu G, Gramegna A, Mantero M, Ori M, Ferrarese M, Codecasa LR, Stainer A, Blasi F, Aliberti S. Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis. ERJ Open Res. 2022;8:00060\u20132022. https:\/\/doi.org\/10.1183\/23120541.00060-2022.","journal-title":"ERJ Open Res."},{"key":"2390_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12879-016-1380-y","volume":"16","author":"L Rindi","year":"2016","unstructured":"Rindi L, Garzelli C. Increase in non-tuberculous mycobacteria isolated from humans in Tuscany, Italy, from 2004 to 2014. BMC Infect Dis. 2016;16:44. https:\/\/doi.org\/10.1186\/s12879-016-1380-y.","journal-title":"BMC Infect Dis"},{"key":"2390_CR22","doi-asserted-by":"publisher","unstructured":"Prato BD, Altieri AM, Carlucci B, Mori PA, Parrella R, Stainer A, Giacomi F, Pesci A, Faverio P, Gruppo di Studio AIPO \u201cPatologie Infettive Respiratorie e Tubercolosi\u201d (2018). Non-tuberculous mycobacterial pulmonary disease: an Italian National survey. Sarcoidosis, Vasculitis, and Diffuse Lung Diseases, 35(1): 21\u201325. https:\/\/doi.org\/10.36141\/svdld.v35i1.6979","DOI":"10.36141\/svdld.v35i1.6979"},{"key":"2390_CR23","doi-asserted-by":"publisher","unstructured":"Stefano Aliberti, Maura Spotti, Giovanni Sotgiu, Maurizio Ferrarese, Paola Francesca Castellotti, Andrea Gramegna, Marina Tadolini, Jessica Mencarini, Gina Gualano, Stefania Cerri, Giuliano Montemurro, Giulia Gardini, Andrea Calcagno, Federico Dente, Michele Trezzi, Paola Faverio, Mario Malerba, Giulia Cucchetto, Enrico Tortoli, Mehdi Mirsaeidi, Antonella Previdi, Andrea Gori, Luigi Ruffo Codecasa, Francesco Blasi. A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE. European Respiratory Journal Sep 2020, 56 (suppl 64) 4344; https:\/\/doi.org\/10.1183\/13993003.congress-2020.4344","DOI":"10.1183\/13993003.congress-2020.4344"},{"key":"2390_CR24","doi-asserted-by":"crossref","unstructured":"World Health Organization Model List of Essential Medicines\u201422nd List, 2021. Geneva: World Health Organization; 2021 (WHO\/MHP\/HPS\/EML\/2021.02). Licence: CC BY-NC-SA 3.0 IGO.","DOI":"10.1530\/ey.19.13.1"},{"key":"2390_CR25","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.3390\/jcm9092968","volume":"9","author":"BG Kim","year":"2020","unstructured":"Kim BG, Kim H, Kwon OJ, Huh HJ, Lee NY, Baek SY, Sohn I, Jhun BW. Outcomes of inhaled amikacin and clofazimine-containing regimens for treatment of refractory mycobacterium avium complex pulmonary disease. J Clin Med. 2020;9:2968. https:\/\/doi.org\/10.3390\/jcm9092968.","journal-title":"J Clin Med"},{"key":"2390_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14787210.2020.1720650","volume":"18","author":"MJ Nasiri","year":"2020","unstructured":"Nasiri MJ, Ebrahimi G, Arefzadeh S, Zamani S, Nikpor Z, Mirsaeidi M. Antibiotic therapy success rate in pulmonary Mycobacterium avium complex: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2020;18:263\u201373. https:\/\/doi.org\/10.1080\/14787210.2020.1720650. (Epub 2020 Jan 27 PMID: 31986933).","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2390_CR27","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1128\/AAC.00770-16.PMID:27480854;PMCID:PMC5038230","volume":"60","author":"BH Jeong","year":"2016","unstructured":"Jeong BH, Jeon K, Park HY, Moon SM, Kim SY, Lee SY, Shin SJ, Daley CL, Koh WJ. Peak plasma concentration of azithromycin and treatment responses in mycobacterium avium complex lung disease. Antimicrob Agents Chemother. 2016;60:6076\u201383. https:\/\/doi.org\/10.1128\/AAC.00770-16.PMID:27480854;PMCID:PMC5038230.","journal-title":"Antimicrob Agents Chemother"},{"key":"2390_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jac\/dky526","volume":"74","author":"MM Ruth","year":"2019","unstructured":"Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J. A bedaquiline\/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria. J Antimicrob Chemother. 2019;74:935\u201343. https:\/\/doi.org\/10.1093\/jac\/dky526.","journal-title":"J Antimicrob Chemother"},{"key":"2390_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jac\/dkw417","volume":"72","author":"NC Ammerman","year":"2017","unstructured":"Ammerman NC, Swanson RV, Tapley A, Moodley C, Ngcobo B, Adamson J, Dorasamy A, Moodley S, Mgaga Z, Bester LA, Singh SD, Almeida DV, Grosset JH. Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo. J Antimicrob Chemother. 2017;72:455\u201361. https:\/\/doi.org\/10.1093\/jac\/dkw417. (Epub 2016 Oct 25 PMID: 27798204).","journal-title":"J Antimicrob Chemother"},{"key":"2390_CR30","doi-asserted-by":"publisher","unstructured":"Padayatchi N, Gopal M, Naidoo R, Werner L, Naidoo K, Master I, O'Donnell MR. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study. J Antimicrob Chemother. 2014 Nov;69(11):3103\u20137. https:\/\/doi.org\/10.1093\/jac\/dku235. Epub 2014 Jun 30. PMID: 24986495; PMCID: PMC4195472.","DOI":"10.1093\/jac\/dku235"},{"key":"2390_CR31","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1056\/NEJMoa0800106.PMID:18687637;PMCID:PMC2673722","volume":"359","author":"CD Mitnick","year":"2008","unstructured":"Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, Fitzmaurice GM, Alcantara Viru FA, Appleton SC, Bayona JN, Bonilla CA, Chalco K, Choi S, Franke MF, Fraser HS, Guerra D, Hurtado RM, Jazayeri D, Joseph K, Llaro K, Mestanza L, Mukherjee JS, Mu\u00f1oz M, Palacios E, Sanchez E, Sloutsky A, Becerra MC. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med. 2008;359:563\u201374. https:\/\/doi.org\/10.1056\/NEJMoa0800106.PMID:18687637;PMCID:PMC2673722.","journal-title":"N Engl J Med"},{"key":"2390_CR32","doi-asserted-by":"publisher","unstructured":"Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, O'Brien P, Chen C, Kaya F, Weiner DM, Chen PY, Song T, Lee M, Shim TS, Cho JS, Kim W, Cho SN, Olivier KN, Barry CE 3rd, Dartois V. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med. 2015 Oct;21(10):1223\u20137. https:\/\/doi.org\/10.1038\/nm.3937. Epub 2015 Sep 7. PMID: 26343800; PMCID: PMC4598290.","DOI":"10.1038\/nm.3937"},{"key":"2390_CR33","doi-asserted-by":"publisher","unstructured":"Faouzi M, Starkus J, Penner R. State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine. Br J Pharmacol. 2015 Nov;172(21):5161\u201373. https:\/\/doi.org\/10.1111\/bph.13283. Epub 2015 Oct 9. PMID: 26276903; PMCID: PMC4687807.","DOI":"10.1111\/bph.13283"},{"key":"2390_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002773.PMID:30939136;PMCID:PMC6445413","volume":"16","author":"N Strydom","year":"2019","unstructured":"Strydom N, Gupta SV, Fox WS, Via LE, Bang H, Lee M, Eum S, Shim T, Barry CE 3rd, Zimmerman M, Dartois V, Savic RM. Tuberculosis drugs\u2019 distribution and emergence of resistance in patient\u2019s lung lesions: a mechanistic model and tool for regimen and dose optimization. PLoS Med. 2019;16: e1002773. https:\/\/doi.org\/10.1371\/journal.pmed.1002773.PMID:30939136;PMCID:PMC6445413.","journal-title":"PLoS Med"},{"key":"2390_CR35","doi-asserted-by":"publisher","unstructured":"Dartois V, Dick T. Drug development challenges in nontuberculous mycobacterial lung disease: TB to the rescue. J Exp Med. 2022 Jun 6;219(6):e20220445. https:\/\/doi.org\/10.1084\/jem.20220445. Epub 2022 May 11. PMID: 35543723; PMCID: PMC9098649.","DOI":"10.1084\/jem.20220445"},{"key":"2390_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2018.00915.PMID:29867826;PMCID:PMC5964161","volume":"16","author":"J Zhang","year":"2018","unstructured":"Zhang J, Leifer F, Rose S, Chun DY, Thaisz J, Herr T, Nashed M, Joseph J, Perkins WR, DiPetrillo K. Amikacin Liposome Inhalation Suspension (ALIS) penetrates non-tuberculous mycobacterial biofilms and enhances amikacin uptake into macrophages. Front Microbiol. 2018;16:915. https:\/\/doi.org\/10.3389\/fmicb.2018.00915.PMID:29867826;PMCID:PMC5964161.","journal-title":"Front Microbiol"},{"key":"2390_CR37","doi-asserted-by":"publisher","unstructured":"Gaviraghi A, de Nicol\u00f2 A, Venuti F, Stroffolini G, Quaranta M, Cat Genova E, Ponzetta L, Alladio F, Marinaro L, D'Avolio A, Calcagno A. Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. https:\/\/doi.org\/10.1128\/aac.00234-24. Epub 2024 May 24. PMID: 38785450; PMCID: PMC11232375.","DOI":"10.1128\/aac.00234-24"},{"key":"2390_CR38","doi-asserted-by":"publisher","first-page":"2302210","DOI":"10.1183\/13993003.02210-2023.PMID:38697635;PMCID:PMC11063616","volume":"63","author":"J van Ingen","year":"2024","unstructured":"van Ingen J, Hoefsloot W, Dartois V, Dick T. Rifampicin has no role in treatment of Mycobacterium avium complex pulmonary disease and bactericidal sterilising drugs are needed: a viewpoint. Eur Respir J. 2024;63:2302210. https:\/\/doi.org\/10.1183\/13993003.02210-2023.PMID:38697635;PMCID:PMC11063616.","journal-title":"Eur Respir J"},{"key":"2390_CR39","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.chest.2023.11.038","volume":"165","author":"SMH Zweijpfenning","year":"2024","unstructured":"Zweijpfenning SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, Stemkens R, Geurts B, van Ingen J, Hoefsloot W. Safety and efficacy of clofazimine as an alternative for rifampicin in mycobacterium avium complex pulmonary disease treatment: outcomes of a randomized trial. Chest. 2024;165:1082\u201392. https:\/\/doi.org\/10.1016\/j.chest.2023.11.038. (Epub 2023 Nov 29 PMID: 38040054).","journal-title":"Chest"},{"key":"2390_CR40","doi-asserted-by":"publisher","unstructured":"Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by\u00a0Mycobacterium avium\u00a0Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559\u20131569. https:\/\/doi.org\/10.1164\/rccm.201807-1318OC. PMID: 30216086.","DOI":"10.1164\/rccm.201807-1318OC"},{"key":"2390_CR41","doi-asserted-by":"publisher","unstructured":"Alffenaar JW, M\u00e4rtson AG, Heysell SK, Cho JG, Patanwala A, Burch G, Kim HY, Sturkenboom MGG, Byrne A, Marriott D, Sandaradura I, Tiberi S, Sintchencko V, Srivastava S, Peloquin CA. Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections. Clin Pharmacokinet. 2021 Jun;60(6):711\u2013725. https:\/\/doi.org\/10.1007\/s40262-021-01000-6. Epub 2021 Mar 10. PMID: 33751415; PMCID: PMC8195771.","DOI":"10.1007\/s40262-021-01000-6"},{"key":"2390_CR42","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/j.ijid.2021.03.064","volume":"113","author":"M Lipman","year":"2021","unstructured":"Lipman M, Kunst H, Loebinger MR, Milburn HJ, King M. Non tuberculous mycobacteria pulmonary disease: patients and clinicians working together to improve the evidence base for care. Int J Infect Dis. 2021;113:S73\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2021.03.064. (Epub 2021 Mar 26 PMID: 33781905).","journal-title":"Int J Infect Dis"},{"key":"2390_CR43","doi-asserted-by":"publisher","unstructured":"Stroffolini G, Gaviraghi A, Penna D, Piccioni P, Venuti F, Botto C, Trezzi M, Betti M, Sestini S, Erba PA, Lupia T, Di Perri G, Aliberti S, Calcagno A. 18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections. A case series on the use of Nuclear Medicine in NTM-PD. J Infect. 2023 Mar 17:S0163\u20134453(23)00142\u20131. https:\/\/doi.org\/10.1016\/j.jinf.2023.03.013. Epub ahead of print. PMID: 36935023.","DOI":"10.1016\/j.jinf.2023.03.013"},{"key":"2390_CR44","unstructured":"https:\/\/www.amantum.org\/, accessed January the 7th 2024."},{"key":"2390_CR45","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.chest.2021.10.003","volume":"161","author":"K Kumar","year":"2022","unstructured":"Kumar K, Loebinger MR. Nontuberculous mycobacterial pulmonary disease: clinical epidemiologic features, risk factors, and diagnosis: the nontuberculous mycobacterial series. Chest. 2022;161:637\u201346. https:\/\/doi.org\/10.1016\/j.chest.2021.10.003. (Epub 2021 Oct 8 PMID: 34627854).","journal-title":"Chest"},{"key":"2390_CR46","doi-asserted-by":"publisher","unstructured":"Prato BD, Altieri AM, Carlucci B, Mori PA, Parrella R, Stainer A, Giacomi F, Pesci A, Faverio P; Gruppo di Studio AIPO \u201cPatologie Infettive Respiratorie e Tubercolosi\u201d. Non-tuberculous mycobacterial pulmonary disease: an Italian National survey. Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(1):21\u201325. https:\/\/doi.org\/10.36141\/svdld.v35i1.6979. Epub 2018 Apr 28. PMID: 32476876; PMCID: PMC7170062.","DOI":"10.36141\/svdld.v35i1.6979"},{"key":"2390_CR47","doi-asserted-by":"publisher","first-page":"00737","DOI":"10.1183\/23120541.00737-2022.PMID:37143838;PMCID:PMC10152245","volume":"9","author":"MR Loebinger","year":"2023","unstructured":"Loebinger MR, van der Laan R, Obradovic M, van Ingen J. Global survey of physician testing practices for nontuberculous mycobacteria. ERJ Open Res. 2023;9:00737\u20132022. https:\/\/doi.org\/10.1183\/23120541.00737-2022.PMID:37143838;PMCID:PMC10152245.","journal-title":"ERJ Open Res"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02390-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T19:49:10Z","timestamp":1739476150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02390-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2390"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02390-y","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}